The 23-valent pneumococcal polysaccharide vaccine. Part II. A cost-effectiveness analysis for invasive disease in the elderly in England and Wales

Alessia Melegaro*, W. John Edmunds

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    45 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'The 23-valent pneumococcal polysaccharide vaccine. Part II. A cost-effectiveness analysis for invasive disease in the elderly in England and Wales'. Together they form a unique fingerprint.

    Keyphrases

    Pharmacology, Toxicology and Pharmaceutical Science

    Agricultural and Biological Sciences